Considerations: Imaging in Urothelial Cell Carcinoma of the Lower Urinary Tract
Publisher
Springer London
Reference23 articles.
1. Sylvester RJ, Van der Meijden APM, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from 7 EORTC trials. Eur Urol. 2006;49:466–77.
2. Goessl C, Knispel HH, Miller K, Klan R. Is routine excretory urography necessary at first diagnosis of bladder cancer? J Urol. 1997;157:480–81.
3. Harranz-Amo F, Diez-Cordero JM, Verdu-Tartajo F, Bueno-Chomon G, Leal-Hernandez F, Bielsa-Carillo A. Need for intravenous urography in patients with primary transitional cancer of the bladder? Eur Urol. 1999;36:221–4.
4. Youssem DM, Gatewood OM, Goldman SM, Marshall FF. Synchronous and metachronous transitional cell carcinoma of theurinary tract: prevalence, incidence, and radiographic detection. Radiology. 1988;167:613–8.
5. Herr HW, Cookson MS, Soloway SM. Upper tract tumors in patients with primary bladder cancer followed for 15 years. J Urol. 1996;156:1286–7.